◀ Back to PTBP2

NR3C2 — PTBP2

Text-mined interactions from Literome

Richards et al., J Immunol 2002 (Coccidioidomycosis) : DCs generated from both groups demonstrated phenotypes characteristic of DCs and stimulated strong allogeneic MLR
Senju et al., Blood 2003 : Upon transfer to new dishes and stimulation with interleukin-4 plus tumor necrosis factor alpha, combined with anti-CD40 monoclonal antibody or lipopolysaccharide, ES-DCs completely became mature DCs , characterized by a typical morphology and higher capacity to stimulate MLR
Luo et al., Zhongguo Shi Yan Xue Ye Xue Za Zhi 2002 : The DCs from the 3 leukemia cell lines stimulated allo-MLR and CTL reaction strongly
Wang et al., Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2004 : MLR was stimulated markedly by DCs transfected with HCV C-Fc gene in comparison with the control group
Krasovsky et al., Planta Med 2009 : Treatment of DCs with HEE also inhibits the ability of DCs to stimulate the mixed lymphocyte reaction (MLR) ... Rather, culturing of DCs with the combination of HEE and SCE leads to partial abrogation of the effects of HEE on the MLR initiated by DCs
Nguyen Pham et al., Cancer research and treatment : official journal of Korean Cancer Association 2007 : Leukemic DCs cultured with CI had a higher allogeneic T cell stimulatory capacity than untreated AML cells, but the addition of IL-4 did not augment the MLR activity of these cells
Qiu et al., Int Immunopharmacol 2012 : The shRNA RelB-DCs can significantly inhibit mixed lymphocyte reaction (MLR) and down-regulate Th1 cytokines and prompt the production of Th2 cytokines
Soligo et al., Br J Haematol 1998 : The DCs generated under flow conditions stimulated the mixed leucocyte reaction (MLR) more than the cells grown in static cultures